We previously showed a relationship between aberrant methylation of CHFR and sensitivity to taxanes, and suggested that aberrant methylation of CHFR could serve as a molecular marker for the sensitivity of cervical cancer to anticancer drugs (44). This evidence concerns the gene CHFR and cervical carcinoma.